Atopic Dermatitis Linked to Sleep, Memory Disturbances
via HealthDayMONDAY, April 27, 2026 -- Adults with more severe atopic dermatitis (AD) are at risk for sleep and memory disturbances, according to a study published online April 21 in Dermatitis.
Jo Anne Lim, M.D., from Universiti Sains Malaysia in Kelantan, and colleagues assessed sleep disturbance and memory dysfunction in 78 adults with AD.
The researchers found that 77 percent reported poor sleep quality and 64 percent showed memory dysfunction. There was an association between sleep latency and disease severity (mild: 32 minutes; moderate: 49 minutes; severe: 63 minutes), while sleep duration decreased (mild: 6.7 hours; moderate: 5.5 hours; severe: 4.5 hours). Highest Everyday Memory Questionnaire-Revised global scores were seen with severe AD (35 versus 19 and 7.9 for moderate and mild, respectively). There also was an association observed between higher Pittsburgh Sleep Quality Index scores and greater memory dysfunction (β = 1.7), poorer retrieval (β = 1.1), and impaired attention tracking (β = 0.7). Memory impairment was independently predicted by poor sleep quality (adjusted odds ratio, 4.4) and daytime dysfunction (adjusted odds ratio, 3.1).
"Assessment of memory complaints may be considered in adults with atopic dermatitis who report sleep problems, in conjunction with optimization of disease control and sleep management," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-28 02:13
Read more
- Drop in NIH Funding Delays Thousands of Studies
- American College of Cardiology, March 28-30
- Machine Learning Model Can Predict Hepatocellular Carcinoma Risk
- America's Sexual Health Report Card Contains Some Surprises
- Website Helps Dementia Patients And Caregivers Bond, Reminisce
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions